Who We Are
EXPERTISE | ADVANCED MANUFACTURING | SPECIALIZED ANIMAL NUTRITION SOLUTIONS
PHARMACELL S.A. – Animal Health Care & Nutrition is a modern Greek company headquartered in Kalochori, Thessaloniki, specializing in the development and manufacturing of advanced animal nutrition solutions. The company is also active in the distribution of veterinary pharmaceuticals and products supporting animal health, nutrition and care.
Founded in 2009 by veterinarian Konstantinos Giannakopoulos, Pharmacell has followed a consistent growth path, investing systematically in manufacturing infrastructure, scientific expertise, Research & Development, quality and technical support.
Today, Pharmacell combines an in-depth understanding of real-world livestock production conditions with advanced manufacturing capabilities and scientifically grounded nutritional approaches, developing solutions that address the evolving demands of modern animal production.
OUR PHILOSOPHY
We transform scientific knowledge, manufacturing expertise and field experience into targeted solutions for modern animal production.
OUR VISION
ADVANCING ANIMAL NUTRITION THROUGH KNOWLEDGE AND A FORWARD-LOOKING APPROACH
Our vision is to contribute meaningfully to the advancement of modern animal production by developing scientifically grounded, specialized and practical nutritional solutions that support animal health, welfare and productivity.
Our approach is built around three core principles:
• Innovation & Scientific Advancement
We continuously invest in Research & Development, advanced manufacturing technologies and the ongoing development of our people.
• Added Value
We transform scientific knowledge into practical solutions that create meaningful value for our partners and the animal production sector.
• Sustainable Progress
With a forward-looking approach, we aim to contribute to an animal production model that is more efficient, resilient and sustainable.
PRODUCTION & INFRASTRUCTURE
NEXT-GENERATION MANUFACTURING
Manufacturing is one of the key pillars of Pharmacell’s growth and a fundamental part of our ability to transform scientific knowledge into specialized nutritional solutions.
Our advanced manufacturing line is designed to deliver high production capacity, flexibility and consistently high-quality standards.
• Production Capacity: 8 tonnes/hour
Our expanded production capacity significantly strengthens our ability to respond efficiently and consistently to the requirements of both the Greek and international markets.
• Integrated Manufacturing Capabilities
Our infrastructure supports the production of premixes, concentrates, feed additives and specialized feed supplements, in both solid and liquid forms, as well as the development of custom-made solutions tailored to specific nutritional and production requirements.
The 3 principles of our manufacturing philosophy:
QUALITY | SAFETY | TRACEABILITY
Pharmacell operates certified management systems in accordance with the international ISO 22000 and FAMI-QS standards, supporting systematic control, full traceability and consistent quality throughout the manufacturing process.
RESEARCH & INNOVATION
FROM SCIENTIFIC KNOWLEDGE TO APPLIED INNOVATION
Research & Development (R&D) is an integral part of Pharmacell’s evolution and a key driver in the development of new and specialized animal nutrition solutions.
We invest in scientific knowledge and applied research, participating in research projects and developing collaborations with universities, research institutions and scientific organizations.
Our objective is to translate research into practical applications with real-world relevance to animal production.
RESEARCH PROJECTS
• MASTIN
Development of innovative approaches to support and manage udder health in sheep.
• HEPA HEALTHY_EGG
Investigation of natural nutritional approaches to support liver health in laying hens.
• NBEE STRONG ANTIBIOTIC OFF
Research and development of natural solutions based on propolis and Greek aromatic and medicinal plants, aiming to support animal health and reduce the need for antibiotic use.
MEDITERRANEAN EXPERTISE
SPECIALIZED EXPERTISE IN HEAT STRESS MANAGEMENT
The conditions of Mediterranean livestock production, characterized by prolonged periods of high temperatures and increased heat load, have created an environment in which Pharmacell has developed particular expertise: the nutritional support of production animals under heat stress conditions.
Heat stress occurs when an animal’s heat production and heat gain exceed its ability to effectively dissipate heat and maintain thermal balance. High environmental temperatures, particularly when combined with elevated relative humidity, can significantly affect animal physiology and metabolism.
Potential effects include:
• Reduced feed intake
• Disruption of fluid and electrolyte balance
• Increased thermoregulatory demands
• Increased metabolic stress
• Reduced productive and reproductive performance
• Compromised animal welfare
FROM HEAT STRESS TO TARGETED NUTRITIONAL SUPPORT
Pharmacell’s approach is based on understanding the physiological and metabolic changes associated with heat stress and translating this knowledge into targeted nutritional strategies.
Our specialized solutions focus on five key areas:
• THERMOREGULATION
Supporting the animal’s physiological mechanisms of adaptation to high environmental temperatures.
• HYDRATION & ELECTROLYTE BALANCE
Supporting fluid and electrolyte balance under conditions of increased heat load.
• FEED INTAKE
Nutritional strategies designed to support feed intake under challenging environmental conditions.
• METABOLIC SUPPORT
Supporting metabolic function during periods of increased physiological stress.
• PRODUCTIVE PERFORMANCE & ANIMAL WELFARE
Supporting physiological function, productive performance and animal welfare during periods of elevated temperatures.
Pharmacell’s Mediterranean Expertise combines experience gained under real livestock production conditions with applied nutritional science, creating a specialized field of expertise for addressing the effects of heat stress in modern animal production.
MEDITERRANEAN EXPERTISE. SCIENCE APPLIED TO CLIMATE RESILIENCE IN ANIMAL NUTRITION.
INTERNATIONAL PRESENCE
GREEK EXPERTISE. INTERNATIONAL OUTLOOK.
International expansion is a key pillar of PHARMACELL’s growth strategy, supported by continuous investment in new markets and long-term international partnerships.
Today, Pharmacell manufactured products are available in 8 markets across Europe and the Middle East, steadily expanding the company’s international footprint:
• Saudi Arabia
• Poland
• Latvia
• Lithuania
• Cyprus
• Albania
• Bulgaria
• North Macedonia
Our experience in the demanding conditions of Mediterranean livestock production, combined with our manufacturing flexibility and scientific expertise, provides a strong foundation for developing solutions that address different production systems, climatic conditions and the requirements of international markets.
GROWTH IN NUMBERS
CONSISTENT GROWTH. INVESTMENT IN MANUFACTURING. EXPANSION INTO NEW MARKETS.
€5,4 εκ. → €14 εκ.
2020 → 2026
REVENUE GROWTH 2026 vs 2020: +159%
OUR PEOPLE
40 PEOPLE. ONE MULTIDISCIPLINARY TEAM.
• 40 Employees
• 5 Specialized Veterinarians
• 6 Animal Production Agronomists & Technologists
• 2 Specialized Food Technologists
• Dedicated R&D Team
Behind Pharmacell’s growth is a multidisciplinary team of professionals with expertise across veterinary science, animal production and nutrition, Research & Development, quality, manufacturing and commercial development.
Our team’s direct and continuous interaction with farmers, veterinarians and industry professionals enables us to understand real-world market and production needs and respond with consistency and effectiveness.
We continuously invest in the training, scientific specialization and professional development of our people, building a team that evolves alongside the company and the changing demands of the industry.
STRATEGIC DIRECTION (2026–2028)
A CLEAR DIRECTION FOR THE FUTURE
Pharmacell is entering a new phase of growth, supported by a significantly strengthened manufacturing base and the capabilities required for the next stage of its development.
Our strategy for 2026–2028 is focused on four key priorities:
• STRENGTHENING OUR POSITION IN THE GREEK MARKET
Continuous development of our network and further strengthening of our presence across key livestock production sectors.
• INTERNATIONAL EXPANSION & GLOBAL PARTNERSHIPS
Expansion of exports, entry into new markets and development of long-term international partnerships.
• R&D & SPECIALIZED SOLUTIONS
Further investment in Research & Development and high-value-added products, in collaboration with academic and research institutions.
• SUSTAINABLE GROWTH & ESG
Continuous improvement of our operations, with a strong focus on environmental responsibility, our people and the principles of modern corporate governance.
With a stronger manufacturing base, continued investment in our people and a clear international orientation, we are building the next phase of Pharmacell’s growth, while remaining consistent with our mission.
SCIENCE. MANUFACTURING. EXPERIENCE. GLOBAL OUTLOOK.
